Rare Heart Risk Found With Checkpoint Inhibitors

Cancer - United States
doi 10.1002/cncr.30731
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Risk of Myocarditis in Patients With Cancer Treated With Immune Checkpoint Inhibitors

Chronicles of Oncology
2018English

Are We Over-Treating With Checkpoint Inhibitors?

British Journal of Cancer
Cancer ResearchOncology
2019English

Rechallenge With Checkpoint Inhibitors in Metastatic Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2020English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Immunotherapy With Checkpoint Inhibitors in Patients With Ovarian Cancer: Still Promising?

Cancer
Cancer ResearchOncology
2019English

Cardiotoxicity of Immune Checkpoint Inhibitors in Patients With Lung Cancer

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

PS4 Clinical Outcomes in Hispanic Patients Treated With Checkpoint Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy